首页> 外文期刊>BMC Ophthalmology >The expression and significance of mTORC1 in diabetic retinopathy
【24h】

The expression and significance of mTORC1 in diabetic retinopathy

机译:MTORC1在糖尿病视网膜病变中的表达及意义

获取原文
获取外文期刊封面目录资料

摘要

BACKGROUND:To investigate the expression and significance of mechanistic target of rapamycin complex 1(mTORC1) in diabetic retinopathy (DR), and to find new targets and new methods for the treatment of DR.METHODS:A DR rat model was prepared by general feeding combined with intraperitoneal injection of 10% streptozotocin (60?mg/kg). The rats were randomly divided into a control group (NDM group) and a diabetes group (DM group). Three months later, the degrees of retinopathy was determined using hematoxylin and eosin staining, and the levels of p-S6, VEGF, and PEDF proteins were detected by immunohistochemistry and western blotting. Human retinal capillary endothelial cells (HRCECs) were cultured in high glucose (HG) conditions, then treated with rapamycin or transfected with siTSC1.The protein levels of p-S6 were assessed by western blotting. The 5-ethynyl-2'-deoxyuridine assay was used to detect cell proliferation, and the Transwell assay was used to detect cell migration.RESULTS:A DM rat model was successfully developed. The expressions of p-S6 and VEGF proteins were significantly increased in the DM group (p??0.05), and the expression of PEDF protein was significantly decreased compared with the NDM group (p??0.05). In vitro, the p-S6 protein, as well as cell proliferation and migration, in HG induced HRCECs were increased (p??0.05) compared with the control (normal glucose) group (p??0.05). After transfection with siTSC1 to activate mTORC1, the expression of p-S6, as well as cell proliferation and migration, were increased. In contrast, rapamycin decreased p-S6 expression, as well as proliferation and migration, in HG induced HRCECs compared to the control group (p??0.05).CONCLUSION:mTORC1 plays an important role in DR. After activation, mTORC1 induced expression of the p-S6 protein, regulated the expressions of VEGF and PEDF proteins, and changed the proliferation and migration of endothelial cells. The mTORC1 can therefore be used as a new target,as well as in the treatment of DR.
机译:背景:探讨雷帕霉素复合物1(MTORC1)在糖尿病视网膜病变(DR)中的力学靶标的表达和意义,并找到新的靶标和治疗DR.Methods的新方法:通过普遍饲养制备DR大鼠模型结合腹膜内注射10%链脲佐菌素(60×Mg / kg)。将大鼠随机分为对照组(NDM组)和糖尿病组(DM组)。三个月后,使用苏木精和曙红染色测定视网膜病变程度,并通过免疫组织化学和蛋白质印迹检测P-S6,VEGF和PEDF蛋白的水平。人视网膜毛细管内皮细胞(HRCEC)在高葡萄糖(HG)条件下培养,然后用雷帕霉素处理或用SitsC1转染。通过Western印迹评估P-S6的蛋白质水平。使用5-乙炔基-2'-脱氧尿苷测定来检测细胞增殖,并使用Transwell测定来检测细胞迁移。结果:成功开发了DM大鼠模型。在DM组中,P-S6和VEGF蛋白的表达显着增加(P?<β05),与NDM组相比,PEDF蛋白的表达显着降低(P?<β05)。在体外,与对照(正常血糖)组相比,P-S6蛋白以及细胞增殖和迁移,在HG诱导的HRCEC中增加(p?<β05)(p?<β05)。用SitsC1转染以激活MTORC1后,P-S6的表达​​以及细胞增殖和迁移增加。相比之下,雷帕霉素降低了P-S6表达,以及扩散和迁移,与对照组相比,HG诱导的HRCEC(P?<β05)。结论:MTORC1在DR中起重要作用。在激活后,MTORC1诱导P-S6蛋白的表达,调节VEGF和PEFF蛋白的表达,并改变内皮细胞的增殖和迁移。因此,MTORC1可以用作新目标,以及博士的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号